Literature DB >> 19812854

Gene cassette arrays, antibiotic susceptibilities, and clinical characteristics of Acinetobacter baumannii bacteremic strains harboring class 1 integrons.

Yi-Tzu Lee1, Li-Yueh Huang, Te-Li Chen, Leung-Kei Siu, Chang-Phone Fung, Wen-Long Cho, Kwok-Woon Yu, Chen-Yi Liu.   

Abstract

BACKGROUND AND
PURPOSE: Acinetobacter baumannii isolates containing class 1 integrons belong to different clones, but only a few strains are successful at causing infection. This study was conducted to compare the characteristics among these clones with different epidemicity.
METHODS: Eighty eight bacteremic isolates of A. baumannii were collected in a medical center in Taiwan during a 3-year period. The gene cassettes and antibiotic susceptibilities of the bacterial isolates were delineated and the patients' characteristics were compared.
RESULTS: Class 1 integrons were detected in 75 isolates (85.2%). Most of the isolates belonged to 2 major clones, but only 1 of the 2 clones caused outbreaks in several hospitals in Taiwan. Restriction analyses of variable regions of the integron revealed identical gene cassettes among isolates within the same clone. The cassette arrays of the 3 clones were aacA4, catB8, aadA1 (clone I, epidemic clone); dhfr XII, unknown open reading frame (orfF), aadA2 (clone II, endemic clone); and aacC1, 2 unknown open reading frames (orfX, orfX'), aadA1a (clone III). The epidemic and endemic strains were multidrug resistant, but the former presented a higher resistance rate to ampicillin-sulbactam. Infections with epidemic strains were significantly associated with prior use of cephalosporins, but didn't contribute to a higher mortality rate.
CONCLUSIONS: Judicious use of cephalosporins and rapid identification using the integron typing method might be helpful for the prevention of further spread of strains with epidemic potential.

Entities:  

Mesh:

Year:  2009        PMID: 19812854

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  7 in total

1.  Class 2 integrons dissemination among multidrug resistance (MDR) clones of Acinetobacter baumannii.

Authors:  María Soledad Ramírez; Amanda Morales; Elisabet Vilacoba; Carolina Márquez; Daniela Centrón
Journal:  Curr Microbiol       Date:  2011-12-24       Impact factor: 2.188

2.  Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities.

Authors:  Galarah D Golanbar; Christopher K Lam; Yi-Ming Chu; Carla Cueva; Stephanie W Tan; Isba Silva; H Howard Xu
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

3.  Molecular epidemiology of integron-associated antimicrobial gene cassettes in the clinical isolates of Acinetobacter baumannii from northern Taiwan.

Authors:  Ming-Feng Lin; Ming-Li Liou; Chi-Chao Tu; Hui-Wen Yeh; Chung-Yu Lan
Journal:  Ann Lab Med       Date:  2013-06-24       Impact factor: 3.464

4.  Endemic Acinetobacter baumannii in a New York hospital.

Authors:  Scott A Weisenberg; Audrey N Schuetz; Elizabeth L Alexander; Elizabeth A Alexander; Brain Eiss; Maryam Behta; Lisa Saiman; Davise H Larone; Stephen G Jenkins; Kyu Y Rhee
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

5.  The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace.

Authors:  Ignasi Roca; Paula Espinal; Xavier Vila-Farrés; Jordi Vila
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

6.  Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.

Authors:  Jing Chen; Hong Li; Jinsong Yang; Rong Zhan; Aiping Chen; Yansheng Yan
Journal:  Int J Environ Res Public Health       Date:  2015-08-21       Impact factor: 3.390

Review 7.  Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii.

Authors:  Mariana Pagano; Andreza Francisco Martins; Afonso Luis Barth
Journal:  Braz J Microbiol       Date:  2016-07-04       Impact factor: 2.476

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.